Acquisitions: #FifthThirdBancorp > #Comerica

Agreed Acquisitions: #Biogen > #ApellisPharmaceuticals; #EliLilly > #CentessaPharmaceuticals; #Novartis > #Excellergy; #Sysco > #RestaurantDepot; #Uber > #Blacklane

SPAC: #IQMQuantumComputers

Closure: #Yupp

Novartis kauft US-amerikanische Excellergy für 2 Mrd. USD Novartis kauft wieder ein und die kalifornische Excellergy für bis zu 2 Mrd. Dollar. Der Antikörper Exl-111 soll die Allergie-Pipelinestärken und über den bisherigen Standard hinausgehen. Der Deal ist...

Novartis kauft US Firma
#Novartis kauft die kalifornische #Excellergy für bis zu 2 Mrd. Dollar. Der #Antikörper Exl-111 soll die #Allergie-Pipeline stärken und über den bisherigen Standard hinausgehen.
transkript.de/artikel/2026...

→ zum Artikel

#immunology #Novartis

Novartis snaps up food allergy firm Excellergy for $2bn Novartis has signed its second M&A deal in the space of a week, pledging to pay up to $2 billion to acquire US food allergy drug developer Excellergy.

With the ink barely dry on one #takeover agreement, #Novartis has signed another, promising to pay up to $2 billion to acquire #US #foodallergydrug developer #Excellergy.

2) ..adayını ABD’li biyoteknoloji firması Synnovation Therapeutics’ten 3 milyar dolara satın aldığını duyurmuştu. Şirket geçen yıl nisan ayında yaptığı açıklamada, ABD’deki tesislerini gelecek elli yılda 32 milyar dolarlık yatırımla büyütmeyi planladığını bildirmişti. #novartis #excellergy

Patient sues Novartis, claiming data-tracking privacy breach A cancer patient in the US has filed a class action lawsuit against Novartis in the US, claiming that the company shared her private health data

A cancer patient in the US has filed a class action lawsuit against #Novartis in the US, claiming that the company illegally shared her private health data using pixel-tracking tools.

pharmaphorum.com/news/patient...

¿Por qué Novartis invierte ¥3.3B ($450M+) en China? 💰

No es expansión. Es una señal.

De Entresto a Cosentyx y Kisqali, acelera ensayos y producción.

¿Qué impulsa este cambio? 👇

#Novartis #ChinaPharma #Biotech #Pharma

Novartis platziert nächsten Milliardendeal in der Onkologie Novartis setzt seine aggressive Expansionsstrategie in der Onkologie fort und greift erneut zu: Für bis zu 3 Mrd. US-Dollar übernimmt der Basler Konzern einen neuartigen PI3Kalpha-Inhibitor von Synnov...

Novartis platziert nächsten Milliardendeal in der Onkologie
#Novartis setzt seine Expansionsstrategie in der #Onkologie fort und greift erneut zu: Für bis zu 3 Mrd. USD übernimmt der Basler Konzern einen neuartigen PI3Kalpha-Inhibitor von Synnovation Therapeutics.
transkript.de/artikel/2026...

Ecolab, Novartis, 3M Lead This Week's Deal Flow Seeking Alpha listed Ecolab, Novartis and 3M on Mar 21, 2026 (19:15:53 GMT); three headline corporates highlight tactical, selective dealmaking and liability-management trends.

Ecolab, Novartis, 3M Lead This Week's Deal Flow: Seeking Alpha listed Ecolab, Novartis and 3M on Mar 21, 2026 (19:15:53 GMT); three headline corporates highlight tactical, selective dealmaking and liability-management trends. Read full analysis 👉 #Ecolab #Novartis #3M #DealFlow #CorporateFinance

#Novartis has reached an #agreement to buy a #PI3K-targeting drug for #breastcancer from #SynnovationTherapeutics, paying a hefty $2 billion upfront for the asset, which is in phase 1/2 testing.

buff.ly/O9xNzu5

US court says pharma giants must face False Claims suit An appeals court in the US has said AbbVie, AstraZeneca, Novartis, and Sanofi must defend claims they defrauded federal and state governments.

An #appealscourt in the #US has said that #AbbVie, #AstraZeneca, #Novartis, and #Sanofi will have to defend claims they #defrauded federal and state government programmes that supply #medicines to low-income and uninsured people.

pharmaphorum.com/news/us-cour...

Significant Growth Expected for Radioligand Therapies Market by 2034 Amid Cancer Treatment Innovations The radioligand therapies market is projected for substantial growth as cancer cases rise and innovative treatments become available, impacting healthcare significantly.

Significant Growth Expected for Radioligand Therapies Market by 2034 Amid Cancer Treatment Innovations #USA #Las_Vegas #Cancer_Treatment #Novartis #Radioligand_Therapies

Helmholtz Munich Launches Collaboration on AI-Driven Kidney Disease Research

Mapping the Kidney at Single-Cell Resolution 🤖

#HelmholtzMunich and #Novartis Biomedical Research are launching a four-year collaboration to advance #KidneyDisease research with #AI-driven modeling, #VirtualCell simulations, & large-scale perturbation analysis.

👉 t1p.de/yf554

#CellAtlas

Mehr Transparenz bitte, Novartis!

Medienmitteilung von #Actares zur Generalversammlung von #Novartis:

www.actares.ch/de/news/nova...

Plus de transparence, s’il vous plaît, Novartis!

Communiqué de presse d'#Actares sur l'assemblée générale de #Novartis:

www.actares.ch/fr/news/nova...

Novartis、Vanrafia（アトラセンタン）第3相ALIGN最終結果：IgA腎症で腎機能低下の抑制を支持 | STELLANEWS.LIFE STELLANEWS.LIFE（ステラニュース・ライフ）は、科学技術・医療・ライフサイエンスの分野における研究 | STELLANEWS.LIFE（ステラニュース・ライフ）は、科学技術・医療・ライフサイエンスの分野における研究

Novartis begins construction of new global biomedical research center in San Diego

ノバルティス、サンディエゴにグローバル生物医学研究センターを建設開始

stellanews.life/technology/8...

#Novartis #SanDiego #BiomedicalResearch #DrugDiscovery #AI #Biotech

Novartis settles with Henrietta Lacks' estate over use of her cancer cells to advance medicine Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine.

#henrietta #lacks #Novartis

Origin | Interest | Match

Dreckige Lieferketten: Wie Pharmakonzerne Emissionen auslagern Die Schweizer Pharma will grüner werden. Neue Zahlen zeigen: Wo produziert wird, bleibt die Umwelt oft auf der Strecke.

www.srf.ch/news/wirtsch... #Novartis #Roche #Lieferkettengesetz #Co2 #Hayek #PhillyCheeseSteak

Novartis settles with Henrietta Lacks' estate over use of her 'stolen' cells to advance medicine Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and...

#Novartis settles with #HenriettaLacks’ estate over use of her ‘stolen’ #cells to advance #medicine

apnews.com/article/henr...

Its about f*ing time, #Novartis

Henrietta Lacks’s Family Settles Suit With Novartis Over Use of Her Cells

Henrietta Lacks’s #Family #Settles #Suit With #Novartis Over #Use of #Her #Cells

www.nytimes.com/2026/02/27/u...

→ zum Artikel

#Forschung #Novartis

Im Nachhaltigkeitsbericht 2024 publizierte #Novartis Ziele zu Wasserverbrauch und Abwasserqualität - 2025 nur noch eines zur Abwasserqualität. Rudert das Unternehmen beim Wasserschutz zurück?

Die #Actares-Positionen zur Generalversammlung:
www.actares.ch/de/news/nova...

Dans son rapport de durabilité 2024, #Novartis a publié des objectifs sur la consommation d’eau et la qualité des eaux usées; en 2025, il n’en reste qu’un sur la qualité des eaux usées. Marche arrière sur la protection de l’eau?

Positions d’ #Actares à l’AG:
www.actares.ch/de/news/nova...

Huge lantern depicting building of Roche in Basel with trump wearing a crown and red ermine robes at front left baring his rear to Novartis and roche to be kissed; figures in windows give the middle finger and complain about 39% taxes; other words say that the crown was stolen from the louvre and there’s a pile of poop ok the crown

#Novartis and #Roche lining up to kiss drumpfs a$$

😱😱😱

#Laterne #Basel #Fasnacht

Pharmalittle: We're reading about Trump's drug-price claims, a Novo deal for obesity drugs, and more In his State of the Union address, President Trump claimed he had brought U.S. prescription drug costs from the highest in the world to the lowest

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Trump’s drug-price claims, a Novo deal for obesity drugs, and more news.. statnews.com/pharmalot/20... #pharma #Trump #obesity #Medicare #antibiotics #Novartis #novonordisk #GSK

Astellas bets on Vir cancer drug, and other licensing deals Our latest round-up of pharma licensing deals features assets from Vir Biotech, Harbour BioMed, Unnatural Products, Genhouse, and CSL.

#pharmalicensingdeals #pharmaceuticalassets #VirBiotech #Vir #HarbourBioMed #UnnaturalProducts #Genhouse #CSL #Astellas #SolsticeOncology #antiCTLA4antibody #Novartis #UnnaturalProducts #macrocyclicpeptidedrugs #GileadSciences #syntheticlethality #GenhouseBio #Arcellx #EliLilly
zurl.co/HOdjt

Pharmalittle: We're reading about an FDA plan for ultra-rare drugs, Novo cutting GLP-1 drug prices, and more The Trump administration released detailed guidance for approving the first bespoke medicines crafted to treat individual patient mutations

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about an FDA plan for ultra-rare drugs, Novo cutting GLP-1 drug prices, and more news.. statnews.com/pharmalot/20... #pharma #obesity #FDA #novonordisk #Ozempic #Wegovy #Novartis #JNJ #Bayer #lawsuit #cancer

Pharmalittle: We're reading about an FDA official's speech, a Grail cancer blood test, and much more The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about an FDA official’s speech, a Grail cancer blood test, and much more news.. statnews.com/pharmalot/20... #pharma #cancer #antibiotics #kickbacks #otc #patents #covid #Novartis #FDA #Roche #Sanofi #BioNTech #Pfizer #Moderna

→ zum Artikel

#Indien #Novartis #Pharmaindustrie #USA